跳至主要内容
临床试验/IRCT20150825023753N8
IRCT20150825023753N8已完成3 期

Study of the effect of syrup of Jollab on cancer-related fatigue in patients with breast cancer: A randomised control trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
Female

入选标准

  • Female gender
  • Age between 18- 70 years old
  • Patients known case of breast cancer
  • Hemoglobin level is at least 8 g / dl
  • Hematocrit level at least 30%
  • The level of TSH is normal

排除标准

  • Patients known case of heart disease with unstable conditions
  • Disabling Pulmonary Disease and History of Asthma
  • Patients known case of severe kidney disease
  • Creatinine level is greater than 2mg / dl
  • Proteinuria
  • The SGOT level is more than 3 times of the normal threshold
  • Bilirubin levels is greater than 2mg / dl
  • Positive history of hypersensitivity to saffron, Rose water and Honey
  • Uncontrolled pain, severe infection, serious illness
  • Positive history of gout or high level of uric acid
  • An individual who uses antidepressants due to depression
  • Simultaneous use of drugs that affect fatigue
  • Unwillingness to participate in the study
  • Active treatment for anemia (transfusion or Epoetin Alfa Injection)

研究者

相似试验